Summary Rare diseases are just that: rare. However, when combined rare diseases affect 3.5% – 5.9% of the worldwide population, and present a growing healthcare
In Episode 67 of 17 Minutes of Science, we are joined by Dr. Gabriel Bossé. Gabriel Bossé is currently a postdoctoral fellow with Randall Peterson
Tune in to episode 64 of 17 Minutes of Science as we talk with Dr. Deborah Kurrasch about her recent paper and why she enjoys
Tune in to episode 63 as we talk with Dr. Alicia McConnell about Camp Zon, a two week research opportunity for high schoolers to get
Dr. Marius Galyan is the founder and CEO of Galyan Bio, Inc., a research company on a mission to discover new therapies for neurodegenerative diseases,
Join us for episode 62 of 17 minutes of Science as we talk with Dr. Jagan Srinivasan from Worcester Polytechnic Institute about his recently published paper using C. elegans to identify a sex-specific behavior.
What is the microbiome? How does it help or hinder health? And, what does recent research indicate? We’ve all had that regret: “oh, I should
For episode 61 of 17 Minutes of Science we are joined by Dr. Zahra Kashi of Kashi Clinical Laboratories. Dr. Kashi joined us first in
Join us for episode 60 of 17 Minutes of Science as we talk with Dr. Adam Saunders, one of our own scientists at InVivo Biosystems.
For episode 59 of 17 Minutes of Science we are joined by Dr. Clarice Aiello, a quantum engineer interested in how quantum physics informs biology
For episode 58 of 17 minutes of Science we are joined by Dr. Oliver Blacque, an Associate Professor in cell biology and genetics at the
Join us for episode 57 of 17 Minutes of Science as we talk with Dr. Pamela Padilla about how scientific societies can build intentional partnerships
When you have to apply for a new job, you are asked to provide a resume, CV, and a cover letter. So why then aren’t
On August 18th, we were joined by Hannah Kistner on 17 Minutes of Science to discuss the homeschool curriculums she has helped develop and share advice and
When you have to apply for a new job, you are asked to provide a resume, CV, and a cover letter. So why then aren’t
Despite being a relatively small and simple organism, the nematode C.elegans and we humans share many similarities at the molecular level. It is for this reason that C.
Alzheimer’s Disease is the most common form of dementia, causing memory loss, confusion, difficulty performing daily tasks, and changes in behavior and judgement. There are
I think the big takeaway for me is that science is relevant again! So let’s shine a light on that” – Sarah Cheesman This week,
Environmental Facilities Testing for COVID-19 InVivo Biosystems has partnered with Enviral Tech to help you safely return to lab We have partnered with Enviral Tech to offer
COVID-19 Research Using C. elegans InVivo Biosystems is ready to help you with your COVID-19 research! COVID-19 research is moving fast, as it should, and what
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Successful zebrafish knock-ins are hard, we are not going to sugar coat it for you, but we at InVivo Biosystems are approaching an 80% success
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Learn more about our Longevity Platform and how it can benefit you by tuning into our recent webinar! Title: A Shortcut to Understanding Longevity: A
Find the ideal model for studying your gene of interest Using CRISPR and other genome editing methods, we can create genetically engineered animal models for
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics Company Changes Operating Name to InVivo Biosystems Eugene, Ore.
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can
Company Changes Operating Name to InVivo Biosystems Eugene, Ore. – March 31, 2020 – NemaMetrix is changing its operating name to InVivo Biosystems as the company
Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! We are
Continuity of Business in Response to COVID-19 As the situation regarding the COVID-19 outbreak changes daily, we wanted to advise you on how we are
Impacted by COVID-19? We are here for you and ready to help We have received reports from some of our customers that the closures at
As the situation regarding the COVID-19 outbreak changes daily, we wanted to advise you on how we are addressing the issue at InVivo Biosystems. Our
Sign up for our upcoming webinar to learn more about our Longevity Platform and how it can benefit you! Title: A Shortcut to Understanding Longevity: A Rapid
CRISPR isn’t just a buzz word anymore, in fact the genome-editing tool is probably the single most popular biological tool and fastest growing technique in
Interested in learning more about the various CRISPR mutation techniques available for zebrafish research? Check out the infographic below to learn more about the CRISPR
Ben Jussila, one of our in-house zebrafish experts, presented his poster “Zebrafish modeling for the clinic: Rapid in vivo functional testing of patient variants for
The introduction of engineered site-specific DNA endonucleases has brought precise genome editing in many model organisms into the realm of possibility. Thanks to precise and
May 20th-26th 2019 is National Epilepsy Week! National Epilepsy Week is dedicated to educating the broader community on epilepsy, supporting those who suffer from the
Did you know April 25th is National DNA Day? This day is held annually to celebrate the completion of the Human Genome Project in 2003 and the discovery
Researching chemicals that may cause damage to the nervous system is very challenging—of the 1,000 known toxic chemicals, only a dozen have been found to
Dr. Janis Weeks is the first to admit her career arc has been anything but traditional. The neuroscientist turned parasite researcher and global health advocate
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.
In Vivo Models
